Universal ultrasound screening for developmental dysplasia of the hip at one month of age appears to be a cost-effective alternative to selective screening, increasing early detection.
Does universal ultrasound screening improve early detection and outcomes in infants compared to selective screening?
Universal ultrasound screening at one month of age is recommended as a cost-effective strategy for early detection and treatment of developmental dysplasia of the hip.
Developmental dysplasia of the hip (DDH) is the most common musculoskeletal disease in infants, and delayed diagnosis can worsen the prognosis. Clinical evidence increasingly supports universal ultrasound (US) screening over selective US screening. The Graf method remains the most widely accepted US technique. Performing an US screening at one month of age seems appropriate as it allows for some hip maturity and early detection, thereby increasing the chances of a favorable outcome. This paper presents an approach to US findings based on the femoral head coverage method. Considering the long-term cost and psychosocial impact of missed DDH cases, universal ultrasound screening appears to be a cost-effective alternative.
Nabil Alassaf (Thu,) conducted a review in Developmental dysplasia of the hip (DDH). Universal ultrasound screening vs. Selective ultrasound screening was evaluated. Universal ultrasound screening for developmental dysplasia of the hip at one month of age appears to be a cost-effective alternative to selective screening, increasing early detection.